# Resolute Holdings Management, Inc.: financial statements, quarterly

RHLD · NYSE · CIK 2039497 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/rhld.md) · [Financials](/companies/rhld/financials.md) · [Filings](/companies/rhld/filings.md) · [Insiders](/companies/rhld/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/rhld/financials.md?period=annual).

## Income statement

| Line item | Unit | period not labelled (2024-03-31) | period not labelled (2024-06-30) | period not labelled (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [104](/filings/0001558370-25-007389.md) | [109](/filings/0001558370-25-010795.md) | [107](/filings/0001104659-25-105336.md) | [101 d](/filings/0001104659-26-027050.md) | [104](/filings/0001104659-26-057120.md) | [120](/filings/0001104659-26-091709.md) | [121](/filings/0001104659-25-105336.md) | [118 d](/filings/0001104659-26-027050.md) | [408](/filings/0001104659-26-057120.md) | [473](/filings/0001104659-26-091709.md) |
| Cost of revenue | $m | [48.8](/filings/0001558370-25-007389.md) | [52.5](/filings/0001558370-25-010795.md) | [51.7](/filings/0001104659-25-105336.md) | [48.3 d](/filings/0001104659-26-027050.md) | [49.4](/filings/0001104659-26-057120.md) | [50.8](/filings/0001104659-26-091709.md) | [49.5](/filings/0001104659-25-105336.md) | [52.2 d](/filings/0001104659-26-027050.md) | [252](/filings/0001104659-26-057120.md) | [308](/filings/0001104659-26-091709.md) |
| Gross profit | $m | [55.2](/filings/0001558370-25-007389.md) | [56.1](/filings/0001558370-25-010795.md) | [55.4](/filings/0001104659-25-105336.md) | [52.5 d](/filings/0001104659-26-027050.md) | [54.5](/filings/0001104659-26-057120.md) | [68.8](/filings/0001104659-26-091709.md) | [71.3](/filings/0001104659-25-105336.md) | [65.5 d](/filings/0001104659-26-027050.md) | [156](/filings/0001104659-26-057120.md) | [165](/filings/0001104659-26-091709.md) |
| Selling, general and administrative | $m | [22.8](/filings/0001558370-25-007389.md) | [22.7](/filings/0001558370-25-010795.md) | [22.6](/filings/0001104659-25-105336.md) | [24.7 d](/filings/0001104659-26-027050.md) | [28.9](/filings/0001104659-26-057120.md) | [28.2](/filings/0001104659-26-091709.md) | [29.9](/filings/0001104659-25-105336.md) | [30.0 d](/filings/0001104659-26-027050.md) | [163](/filings/0001104659-26-057120.md) | [130](/filings/0001104659-26-091709.md) |
| Operating income | $m | [32.4](/filings/0001558370-25-007389.md) | [33.4](/filings/0001558370-25-010795.md) | [32.8](/filings/0001104659-25-105336.md) | [(2.4)](/filings/0001410578-25-000595.md) | [25.6](/filings/0001104659-26-057120.md) | [40.6](/filings/0001104659-26-091709.md) | [41.5](/filings/0001104659-25-105336.md) | [35.6 d](/filings/0001104659-26-027050.md) | [(5.8)](/filings/0001104659-26-057120.md) | [35.2](/filings/0001104659-26-091709.md) |
| Interest expense | $m | [6.5](/filings/0001558370-25-007389.md) | [6.4](/filings/0001558370-25-010795.md) | [6.3](/filings/0001104659-25-105336.md) | [0.9 d](/filings/0001104659-26-027050.md) | [3.5](/filings/0001104659-26-057120.md) | [3.5](/filings/0001104659-26-091709.md) | [3.4](/filings/0001104659-25-105336.md) | [3.1 d](/filings/0001104659-26-027050.md) | [30.1](/filings/0001104659-26-057120.md) | [34.2](/filings/0001104659-26-091709.md) |
| Income tax | $m | [0.0](/filings/0001558370-25-007389.md) | [0.0](/filings/0001558370-25-010795.md) | [0.0](/filings/0001104659-25-105336.md) | [(0.0)](/filings/0001410578-25-000595.md) | [0.6](/filings/0001104659-26-057120.md) | [0.3](/filings/0001104659-26-091709.md) | [0.1](/filings/0001104659-25-105336.md) | [(0.0) d](/filings/0001104659-26-027050.md) | [(49.8)](/filings/0001104659-26-057120.md) | [42.8](/filings/0001104659-26-091709.md) |
| Net income | $m | [26.4](/filings/0001104659-25-105336.md) | [27.9](/filings/0001104659-25-105336.md) | [27.8](/filings/0001104659-25-105336.md) | [(2.3)](/filings/0001410578-25-000595.md) | [(3.4)](/filings/0001104659-26-057120.md) | [(0.6)](/filings/0001104659-26-091709.md) | [(0.2)](/filings/0001104659-25-105336.md) | [(1.7) d](/filings/0001104659-26-027050.md) | [61.5](/filings/0001104659-26-057120.md) | [(12.4)](/filings/0001104659-26-091709.md) |
| Diluted EPS | $ per share | not reported | not reported | not reported | [(2334.00)](/filings/0001410578-25-000595.md) | [(0.39)](/filings/0001104659-26-057120.md) | [(0.07)](/filings/0001104659-26-091709.md) | [(0.03)](/filings/0001104659-25-105336.md) | not reported | [7.19](/filings/0001104659-26-057120.md) | [(1.53)](/filings/0001104659-26-091709.md) |
| Basic EPS | $ per share | not reported | not reported | not reported | [(2334.00)](/filings/0001410578-25-000595.md) | [(0.39)](/filings/0001104659-26-057120.md) | [(0.07)](/filings/0001104659-26-091709.md) | [(0.03)](/filings/0001104659-25-105336.md) | not reported | [7.27](/filings/0001104659-26-057120.md) | [(1.53)](/filings/0001104659-26-091709.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: us-gaap:GrossProfit
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:ProfitLoss, us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | period not labelled (2023-12-31) | period not labelled (2024-03-31) | period not labelled (2024-06-30) | period not labelled (2024-09-26) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | not reported | not reported | not reported | not reported | [71.6](/filings/0001104659-26-027050.md) | [71.0](/filings/0001558370-25-007389.md) | [99.9](/filings/0001104659-26-091709.md) | [98.2](/filings/0001104659-25-105336.md) | [161](/filings/0001104659-26-091709.md) | [113](/filings/0001104659-26-057120.md) | [117](/filings/0001104659-26-091709.md) |
| Current assets | $m | not reported | not reported | not reported | not reported | [167](/filings/0001104659-26-027050.md) | [176](/filings/0001558370-25-007389.md) | [217](/filings/0001558370-25-010795.md) | [259](/filings/0001104659-25-105336.md) | [298](/filings/0001104659-26-091709.md) | [938](/filings/0001104659-26-057120.md) | [818](/filings/0001104659-26-091709.md) |
| Total assets | $m | not reported | not reported | not reported | not reported | [202](/filings/0001104659-26-027050.md) | [214](/filings/0001558370-25-007389.md) | [253](/filings/0001104659-26-091709.md) | [293](/filings/0001104659-25-105336.md) | [333](/filings/0001104659-26-091709.md) | [6,215](/filings/0001104659-26-057120.md) | [6,127](/filings/0001104659-26-091709.md) |
| Current liabilities | $m | not reported | not reported | not reported | not reported | [50.1](/filings/0001104659-26-027050.md) | [48.8](/filings/0001558370-25-007389.md) | [63.9](/filings/0001558370-25-010795.md) | [70.5](/filings/0001104659-25-105336.md) | [77.6](/filings/0001104659-26-091709.md) | [589](/filings/0001104659-26-057120.md) | [605](/filings/0001104659-26-091709.md) |
| Total liabilities | $m | not reported | not reported | not reported | not reported | [238](/filings/0001104659-26-027050.md) | [238](/filings/0001558370-25-007389.md) | [249](/filings/0001558370-25-010795.md) | [252](/filings/0001104659-25-105336.md) | [255](/filings/0001104659-26-091709.md) | [3,134](/filings/0001104659-26-057120.md) | [3,074](/filings/0001104659-26-091709.md) |
| Long-term debt | $m | not reported | [184](/filings/0001558370-25-007389.md) | not reported | not reported | [184](/filings/0001104659-26-027050.md) | [181](/filings/0001558370-25-007389.md) | [177](/filings/0001558370-25-010795.md) | [173](/filings/0001104659-25-105336.md) | [169](/filings/0001104659-26-091709.md) | [2,178](/filings/0001104659-26-057120.md) | [2,154](/filings/0001104659-26-091709.md) |
| Current portion of debt | $m | not reported | [11.3](/filings/0001558370-25-007389.md) | not reported | not reported | [11.3](/filings/0001104659-26-027050.md) | [12.5](/filings/0001558370-25-007389.md) | [13.8](/filings/0001558370-25-010795.md) | [15.0](/filings/0001104659-25-105336.md) | [15.0](/filings/0001104659-26-091709.md) | [9.0](/filings/0001104659-26-057120.md) | [24.0](/filings/0001104659-26-091709.md) |
| Shareholders' equity | $m | [(199)](/filings/0001104659-26-027050.md) | [(185)](/filings/0001104659-25-105336.md) | [(205)](/filings/0001104659-25-105336.md) | [0.0](/filings/0001410578-25-000595.md) | [(0.8)](/filings/0001104659-26-027050.md) | [8.9](/filings/0001558370-25-007389.md) | [9.6](/filings/0001558370-25-010795.md) | [10.8](/filings/0001104659-25-105336.md) | [6.5](/filings/0001104659-26-091709.md) | [30.3](/filings/0001104659-26-057120.md) | [(31.5)](/filings/0001104659-26-091709.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest, us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | period not labelled (2024-03-31) | period not labelled (2024-06-30) | period not labelled (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [35.7](/filings/0001558370-25-007389.md) | [36.1 d](/filings/0001558370-25-010795.md) | [36.3 d](/filings/0001104659-25-105336.md) | [(0.5)](/filings/0001410578-25-000595.md) | [18.4](/filings/0001104659-26-057120.md) | [49.0 d](/filings/0001104659-26-091709.md) | [59.5 d](/filings/0001104659-25-105336.md) | [69.2 d](/filings/0001104659-26-027050.md) | [(117)](/filings/0001104659-26-057120.md) | [93.6 d](/filings/0001104659-26-091709.md) |
| Capital expenditure | $m | [1.6](/filings/0001558370-25-007389.md) | [1.5 d](/filings/0001558370-25-010795.md) | [1.7 d](/filings/0001104659-25-105336.md) | [2.6 d](/filings/0001104659-26-027050.md) | [0.6](/filings/0001104659-26-057120.md) | [1.0 d](/filings/0001104659-26-091709.md) | [1.4 d](/filings/0001104659-25-105336.md) | [3.9 d](/filings/0001104659-26-027050.md) | [7.4](/filings/0001104659-26-057120.md) | [12.3 d](/filings/0001104659-26-091709.md) |
| Share repurchases | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | [38.0](/filings/0001104659-26-057120.md) | [49.5 d](/filings/0001104659-26-091709.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | period not labelled (2024-03-31) | period not labelled (2024-06-30) | period not labelled (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | thousands of shares | [8,526](/filings/0001558370-25-007389.md) | [8,526](/filings/0001558370-25-010795.md) | [8,526](/filings/0001104659-25-105336.md) | [1.0](/filings/0001410578-25-000595.md) | [8,526](/filings/0001104659-26-057120.md) | [8,526](/filings/0001104659-26-091709.md) | [8,526](/filings/0001104659-25-105336.md) | [8,547](/filings/0001104659-26-057120.md) | [8,103](/filings/0001104659-26-091709.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 7,819,595 at 2026-08-05, from the cover of the [10-Q filed 2026-08-06](/filings/0001104659-26-091709.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:50 ET. No prices; not investment advice.